Cargando…

The mitochondrial calcium uniporter: a new therapeutic target for Parkinson’s disease-related cardiac dysfunctions?

Detalles Bibliográficos
Autores principales:	Scorza, Fúlvio Alexandre, Menezes-Rodrigues, Francisco Sandro, Olszewer, Efraín, Errante, Paolo Ruggero, Tavares, José Gustavo Patrão, Scorza, Carla Alessandra, Ferraz, Henrique Ballalai, Finsterer, Josef, Caricati-Neto, Afonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945289/ https://www.ncbi.nlm.nih.gov/pubmed/31939558 http://dx.doi.org/10.6061/clinics/2020/e1299

Ejemplares similares

Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2020)

Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2019)

Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection
por: Caricati-Neto, Afonso, et al.
Publicado: (2019)

Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2021)

Parkinson-related neuropathy
por: Finsterer, Josef, et al.
Publicado: (2021)

Myotonic Dystrophy-1 and Parkinson's Disease: Clarify the Role of CTG-repeat Size and Variants in VPS13C, SYNJ1, and DNAJC6
por: Finsterer, Josef, et al.
Publicado: (2023)

Sudden unexpected death in Parkinson’s disease (SUDPAR): a review of publications since the decade of the brain
por: Scorza, Fulvio A., et al.
Publicado: (2017)

Domperidone, Parkinson disease and sudden cardiac death: Mice and men show the way
por: Scorza, Fulvio A, et al.
Publicado: (2016)

Prevention of Parkinson’s disease-related sudden death
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Parkinson's Disease: The Dirty Truth about the Air
por: Scorza, Fulvio A., et al.
Publicado: (2023)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Low serum lipid levels as predictors of future suicide attempt in Parkinson's disease
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Parkinson's disease in LGBT+ older adults: The unexplored connection
por: Scorza, Fulvio A., et al.
Publicado: (2023)

MicroRNAs in Sudden Death in Parkinson's Disease: Could the News be Packaged?
por: Guimarães-Marques, Marcia, et al.
Publicado: (2021)

SARS-CoV-2 associated rhabdomyolysis in 32 patients
por: FINSTERER, JOSEF, et al.
Publicado: (2021)

Before diagnosing postoperative chemical meningitis, all infectious causes must be thoroughly ruled out
por: Finsterer, Josef, et al.
Publicado: (2023)

Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome
por: Finsterer, Josef, et al.
Publicado: (2018)

Phenotypic spectrum of FARS2-deficiency
por: Finsterer, Josef, et al.
Publicado: (2017)

Antiepileptic treatment may determine the outcome of FARS2 mutation carriers
por: Finsterer, Josef, et al.
Publicado: (2018)

Diagnosing myasthenic crisis in SARS-CoV-2 infected patients requires adherence to appropriate criteria
por: Finsterer, Josef, et al.
Publicado: (2020)

Early white matter changes on diffusion tensor imaging in amyotrophic lateral sclerosis
por: Finsterer, Josef, et al.
Publicado: (2020)

Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
por: Finsterer, Josef, et al.
Publicado: (2021)

Presentation and pathophysiology of neuro-COVID
por: Finsterer, Josef, et al.
Publicado: (2021)

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)

Determining prediction factors of post-neurosurgical thrombosis requires consideration of the entire spectrum of risk factors
por: Finsterer, Josef, et al.
Publicado: (2022)

Guillain-Barre syndrome related to SARS-CoV-2 vaccinations
por: Finsterer, Josef, et al.
Publicado: (2022)

Long post-COVID-vaccination syndrome manifesting as temperature-sensitive myalgia and hyper-CKemia
por: Finsterer, Josef, et al.
Publicado: (2023)

Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance
por: Finsterer, Josef, et al.
Publicado: (2023)

Pseudomonas aeruginosa ventriculitis following pancytopenia due to myelodysplastic syndrome with an excess of blasts type 2
por: Scorza, Carla Alexandra, et al.
Publicado: (2023)

Management of Leigh syndrome due to NDUFAF6 variants
por: Finsterer, Josef, et al.
Publicado: (2019)

Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
por: Finsterer, Josef, et al.
Publicado: (2020)

Clinical and Pathophysiologic Spectrum of Neuro-COVID
por: Finsterer, Josef, et al.
Publicado: (2021)

Fasciculation frequency is a questionable biomarker for motor unit loss in amyotrophic lateral sclerosis
por: Finsterer, Josef, et al.
Publicado: (2020)

Perspectives of Neuro-COVID: Myasthenia
por: Finsterer, Josef, et al.
Publicado: (2021)

Mental compromise in SARS-CoV-2 infected patients is multicausal, organic or inorganic
por: Finsterer, Josef, et al.
Publicado: (2021)

Neuro-COVID Requires Comprehensive Work-up
por: Finsterer, Josef, et al.
Publicado: (2021)

Apparent onset of COVID-19 after onset of SARS-CoV-2 associated Guillain-Barre syndrome
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
por: Finsterer, Josef, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bfq0tuvuh3oc25apgsi51vtsce